206 related articles for article (PubMed ID: 26446643)
1. The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients.
Choi JR; Jang Y; Kim Yoon S; Park JK; Sorn SR; Park MY; Lee M
Yonsei Med J; 2015 Nov; 56(6):1604-12. PubMed ID: 26446643
[TBL] [Abstract][Full Text] [Related]
2. Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect.
Teng MS; Hsu LA; Wu S; Sun YC; Juan SH; Ko YL
PLoS One; 2015; 10(4):e0122664. PubMed ID: 25875811
[TBL] [Abstract][Full Text] [Related]
3. Effects of smoking and obesity on the association between CDH13 (rs3865188) and adiponectin among Korean men: the KARE study.
Jo J; Sull JW; Park EJ; Jee SH
Obesity (Silver Spring); 2012 Aug; 20(8):1683-7. PubMed ID: 21617638
[TBL] [Abstract][Full Text] [Related]
4. CDH13 genotype-dependent association of high-molecular weight adiponectin with all-cause mortality: the J-SHIPP study.
Uetani E; Tabara Y; Kawamoto R; Onuma H; Kohara K; Osawa H; Miki T
Diabetes Care; 2014 Feb; 37(2):396-401. PubMed ID: 24041676
[TBL] [Abstract][Full Text] [Related]
5. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
[TBL] [Abstract][Full Text] [Related]
6. [Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity].
Yan WJ; Wu J; Mo J; Huang CW; Peng LW; Xu L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):47-50. PubMed ID: 19149923
[TBL] [Abstract][Full Text] [Related]
7. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ
Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Association Study on Adiponectin-Mediated Suppression of HDL-C Levels in Taiwanese Individuals Identifies Functional Haplotypes in
Er LK; Wu S; Cheng T; Ko YL; Teng MS
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680977
[No Abstract] [Full Text] [Related]
9. CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass.
Kitamoto A; Kitamoto T; Nakamura T; Matsuo T; Nakata Y; Hyogo H; Ochi H; Kamohara S; Miyatake N; Kotani K; Mineo I; Wada J; Ogawa Y; Yoneda M; Nakajima A; Funahashi T; Miyazaki S; Tokunaga K; Masuzaki H; Ueno T; Chayama K; Hamaguchi K; Yamada K; Hanafusa T; Oikawa S; Sakata T; Tanaka K; Matsuzawa Y; Hotta K
J Atheroscler Thromb; 2016; 23(3):309-19. PubMed ID: 26423718
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension.
Jonas K; Magoń W; Podolec P; Kopeć G
Med Sci Monit; 2019 Jan; 25():746-753. PubMed ID: 30683836
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
[TBL] [Abstract][Full Text] [Related]
12. Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.
Gupta M; Szmitko PE; Tsigoulis M; Braga MF; Kajil M; Herjikaka S; Quan A; Teoh H; Verma S
J Cardiovasc Pharmacol; 2010 Sep; 56(3):241-5. PubMed ID: 20505518
[TBL] [Abstract][Full Text] [Related]
13. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
[TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
19. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
20. Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.
Matsuda M; Tamura R; Kanno K; Segawa T; Kinoshita H; Nishimoto O; Nishiyama H; Kawamoto T
Diabetol Metab Syndr; 2013 Dec; 5(1):77. PubMed ID: 24314067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
